Evidence map›Paper›PMID 40641039›Full record

ArticleThe FEBS journal2025

High-throughput screening identifies a previously undescribed checkpoint controlling mitotic progression in response to DNA damage.

Nan Li, Rachel Gatenby, Thomas Walne, Caroline Daye, Steven Watson, Priya Lata, Stephen Brown, Ruth Thompson

Abstract read
In one paragraph

Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nan LiDivision of Clinical Medicine, Faculty of Health, University of Sheffield, UK.
Rachel GatenbyDivision of Clinical Medicine, Faculty of Health, University of Sheffield, UK.
Thomas WalneDivision of Clinical Medicine, Faculty of Health, University of Sheffield, UK.
Caroline DayeDivision of Clinical Medicine, Faculty of Health, University of Sheffield, UK.
Steven WatsonDivision of Clinical Medicine, Faculty of Health, University of Sheffield, UK.
Priya LataDivision of Clinical Medicine, Faculty of Health, University of Sheffield, UK.
Stephen BrownSchool of Biosciences, Faculty of Science, University of Sheffield, UK.
Ruth ThompsonDivision of Clinical Medicine, Faculty of Health, University of Sheffield, UK.ORCID https://orcid.org/0000-0002-0828-4170

Funding

Royal Society DH160106Royal Society DHF/R/231004
6 · The paper itself

Abstract

Following DNA damage, the cell cycle can be slowed or halted to allow for DNA repair. However, the mechanisms underpinning mitotic delay in response to DNA damage are unclear. Through an unbiased high-throughput screen, here, we have identified superoxide dismutase 1 (SOD1) as an essential factor mediating mitotic delay in response to DNA damage. Cells with damaged DNA arrest at metaphase, indicating involvement of the spindle assembly checkpoint (SAC); however, this response is lost following SOD1 depletion. Furthermore, whilst depletion of SAC proteins promotes rapid cell division (often less than 10 min) in all conditions, SOD1 depletion has no impact on mitotic progression either in unperturbed mitosis or in response to spindle poisons and does not decrease the mitotic transit time beyond the normal rate. Cells depleted of SOD1 display damaged centromeres and mitotic defects but no longer exhibit DNA-damage-induced mitotic delay. SOD1 has previously been shown to mediate redox control of phosphatases such as PP2a. In response to DNA damage, we observed elevated phosphorylation of SAC protein BubR1 and the kinetochore protein KNL1. Dephosphorylation of these proteins is required for SAC silencing, and PP2a has previously been implicated in this. Following SOD1 depletion, we observed elevated PP2a activity and decreased phosphorylation of BubR1 and KNL1. We propose that, in response to damage, SOD1 restrains PP2a activity, resulting in elevated BubR1 and KNL1 phosphorylation leading to persistent SAC activation.

Indexed as

DNA DamageMitosisM Phase Cell Cycle CheckpointsSuperoxide DismutaseCell Cycle ProteinsHeLa CellsHigh-Throughput Screening AssaysHumansMicrotubule-Associated ProteinsPhosphorylationProtein Phosphatase 2Protein Serine-Threonine KinasesSuperoxide Dismutase-1BUB1 protein, humanCell Cycle ProteinsMicrotubule-Associated ProteinsProtein Phosphatase 2Protein Serine-Threonine KinasesSOD1 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1cell cyclecheckpointDNA damagemitosisSOD1

Identifiers

PMID40641039
PMCPMC12713330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.